Satellos Bioscience Inc. (MSLE)

NASDAQ: MSLE · USD

$6.37

-0.03 (-0.5%)· Recorded snapshot

Market cap	136.4M
Net income (ttm)	-34.6M
EPS (ttm)	-$2.02
Shares out	21.2M
Volume	14,461.094
Beta	1.15

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -34.6M
EPS (ttm): -$2.02
Market cap: 136.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-70.4

P25 n/aP50 n/aP75 n/a

ROIC-45.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All MSLE indicators

Market & fundamental data

Available fields

169

Groups with data

Currency

USD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001421642
Company name	Satellos Bioscience Inc.
Country	Canada
Country code	US
CUSIP number	80401L803
Earnings date	2026-11-15
Earnings time	bmo
Employees	21
Employees change	4
Employees growth	23.53%
Enterprise value	$73.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-08-16
Fiscal year end	December
Founded	2018
Industry	Biotechnology
Is primary listing	No
Is SPAC	No
ISIN number	CA80401L8033
Last earnings date	2026-08-13
Last refreshed	2026-11-04
Last stock split date	2026-01-30
Last stock split type	Reverse
Market cap	$136.4M
Market cap category	Micro-Cap
Next earnings date	2026-11-15
Options	No
Price	$6.37
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-03
Symbol	MSLE
Website	https://satellos.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-31.78%
FCF / EV yield	-39.37%
FCF yield	-21.26%
P/B ratio	2.28x
Price / tangible book value	2.28x
Sector forward P/E	23.32x
Sector P/E	49.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-1.6M
ROA	-41.89%
ROA (5Y)	-41.82%
ROCE	-59.79%
ROE	-70.45%
ROE (5Y)	-131.57%
ROIC	-45.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-7,000
Depreciation and amortization	$5,000
EBIT	$-35.8M
EBITDA	$-35.8M
EPS	$-2.02
FCF per share	$-1.37
Financing cash flow	$52.8M
Free cash flow	$-29M
Free cash flow minus SBC	$-32.4M
Gross profit	$-9.5M
Income taxes	$154,000
Investing cash flow	$-54.6M
Net cash flow	$-30.8M
Net income	$-34.6M
Operating cash flow minus SBC	$-32.4M
Operating income	$-35.8M
Stock-based compensation	$3.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$2.87
Debt / equity	0
Long-term assets	$7,000
Long-term liabilities	$0
Net cash (debt)	$61.8M
Net cash / market cap	45.33%
Net cash growth	61.81%
Net debt / equity	-1.03
Piotroski F-Score	1
Property, plant and equipment	$7,000
Shareholders' equity	$59.9M
Tangible book value	$59.9M
Tangible book value per share	$2.87
Total assets	$65.8M
Total cash	$61.8M
Total debt	$0
Total liabilities	$5.9M
WACC	10.55%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$65.8M
Current liabilities	$5.9M
Current ratio	11.22
Net working capital	$-1.9M
Quick ratio	10.68
Working capital	$59.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-46.32%
Dividend yield	0%
Shareholder yield	-46.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$7.94
1D price change	-0.47%
1M price change	-25.06%
1M total return	-25.06%
1W price change	-7.41%
1W total return	-7.41%
1Y price change	-1.98%
1Y return CAGR	-1.99%
1Y total return	-1.99%
20-day SMA	$6.80
200-day SMA	$8.47
3M price change	-36.24%
3M total return	-36.24%
3Y price change	113.69%
3Y return CAGR	28.8%
3Y total return	113.7%
50-day SMA	$8.15
50-day SMA vs 200-day SMA	50under200
52-week high	$13.40
52-week high date	2026-03-03
52-week low	$5.30
52-week low date	2025-11-14
5Y price change	-51.5%
5Y return CAGR	-13.47%
5Y total return	-51.5%
6M price change	-18.85%
6M total return	-18.85%
All-time high	$21.82
All-time high date	2021-08-18
All-time low	$0.04
All-time low date	2021-12-21
Average true range (ATR)	$0.51
Average volume	44.7K
Beta (5Y)	1.15
Change from 52-week high	-52.44%
Change from 52-week low	20.12%
Change from all-time high	-70.8%
Change from all-time low	15,066.67%
Change from open	-0.31%
Day's gap	-0.16%
Dollar volume	$92,117
High price	$6.52
Low price	$6.37
Monthly RSI	47.14
Open price	$6.39
Position in 52-week range	0%
Previous close	$6.40
Price vs 150-day SMA	-19.74%
Price vs 20-day SMA	-6.32%
Price vs 200-day SMA	-24.78%
Price vs 50-day SMA	-21.81%
Relative volume	0.32
RSI	36.49
Sharpe ratio	0.33
Sharpe ratio (3Y)	0.57
Sortino ratio	0.6
Sortino ratio (3Y)	1
Volume	14.5K
Weekly RSI	40.36
YTD price change	8.33%
YTD total return	8.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18M
Float percentage	84.93%
Shares change (QoQ)	13%
Shares change (YoY)	46.32%
Shares held by insiders	6.94%
Shares held by institutions	41.6%
Shares outstanding	21.2M
Short % of float	0.54%
Short % of shares	0.46%
Short ratio	1.5 days

Deeper analysis on MSLE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MSLE report

Is a complete MSLE research report available?

No complete published report is available for Satellos Bioscience Inc. (MSLE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Satellos Bioscience Inc. (MSLE)

Price

Financial snapshot

Fair-value bridge

Latest news · MSLE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MSLE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MSLE

Frequently asked questions